申请人:Janssen Pharmaceutica NV
公开号:US20200289539A1
公开(公告)日:2020-09-17
The present invention relates novel substituted nucleoside analogues of Formula (I)
wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as PRMT5 inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.